Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Reductase Inhibitors

Reductase Inhibitors Newsletter

To Your Good Health: PSA level remains consistently high amid no findings of cancer 07 Jul 2025 23:43 GMT
… might consider a 5-alpha reductase inhibitor to reduce your prostate cancer …
Prostate-Specific Antigen Monitoring in Men Using 5-Alpha Reductase Inhibitors 25 Feb 2025 12:55 GMT
… prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, … methodology, concerns about 5-alpha reductase inhibitors’ effects, biopsy triggers, … patients treated with 5-alpha reductase inhibitors. Source: bmcurol.biomedcentral.com …
Repertory-Guided Homeopathic Management of Androgenetic Alopecia: An Individualized Approach to a Common Trichological Disorder 04 Jul 2025 19:03 GMT
… and type II 5-alpha-reductase inhibitor and has shown superior efficacy …
The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia. 13 Jan 2025 18:07 GMT
… fail conservative treatment. 5-alpha-reductase inhibitors (5-ARIs) is the only …
Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. 25 Oct 2024 09:04 GMT
α-1 blockers and dutasteride are widely used as agents to treat benign prostatic hyperplasia (BPH); the impact of these drugs on prostatic inflammation is still unclear. Herein, we investigated the impact of α-1 blockers and dutasteride treatment of BPH in …
Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective 17 Oct 2024 16:13 GMT
… Bowen, Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia …
5-α Reductase Inhibitors and Prostate Cancer Mortality - Beyond the Abstract 20 Sep 2024 23:53 GMT
5-α reductase inhibitors (5-ARIs) finasteride and dutasteride … cancer using a dual 5α-reductase inhibitor, dutasteride. Expert Rev Anticanc 8 … : Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and …
5-α Reductase Inhibitors and Prostate Cancer Mortality. 29 Aug 2024 11:05 GMT
5-alpha-reductase-inhibitors (5-ARIs) are approved for …
Suicide and Intentional Self-harm Among Older Men Treated With 5-Alpha Reductase Inhibitor or Alpha-blockers for Benign Prostatic Hyperplasia. 07 Jul 2024 22:50 GMT
… in older men using 5-α reductase inhibitors (5-ARIs) and alpha-blockers …
ASCO 2024: A Phase II Trial of Enzalutamide with 5-Alpha Reductase Inhibitors as an ADT–Sparing Approach for Older Men with CSPC 04 Jun 2024 13:39 GMT
… of enzalutamide with 5-alpha reductase inhibitors as an ADT–sparing approach … events from ADT. 5-alpha reductase inhibitors inhibit the conversion of testosterone … of enzalutamide with 5-alpha reductase inhibitors as an ADT–sparing approach …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS